Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 28, 2006; 12(40): 6522-6526
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6522
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6522
Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer
Hiroshi Imamura, Masataka Ikeda, Hiroshi Furukawa, Department of Surgery, Sakai Municipal Hospital, Osaka, Japan
Toshimasa Tsujinaka, Kazumasa Fujitani, Department of Surgery, Osaka National Hospital, Osaka, Japan
Kenji Kobayashi, Department of Surgery, Kinki Central Hospital, Hyogo, Japan
Hiroyuki Narahara, Hideaki Tsukuma, Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
Michio Kato, Department of Surgery, Kinki University School of Medicine, Osaka, Japan
Haruhiko Imamoto, Department of Surgery, Kansai Rosai Hospital, Hyogo, Japan
Arimichi Takabayashi, Department of Surgery, Kitano Hospital & Research Institute, Osaka, Japan
Correspondence to: Hiroshi Imamura, Department of Surgery, Sakai Municipal Hospital, 1-1-1, Minamiyasui-cho, Sakai, Osaka 590-0064, Japan. imamura-h@city.sakai.osaka.jp
Telephone: +81-72-2211700 Fax: +81-72-2253303
Received: June 21, 2006
Revised: July 10, 2006
Accepted: July 18, 2006
Published online: October 28, 2006
Revised: July 10, 2006
Accepted: July 18, 2006
Published online: October 28, 2006
Core Tip